Efficacy Trial of Zonisamide for Myoclonus Dystonia
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
Myoclonus Dystonia is a disease in which myoclonus distort the precision of movements and so
cause a handicap in the movements of the everyday life. Response to oral medications may be
incomplete and surgery may cause operating risk.
Zonisamide is an antiepileptic drug which could bring a therapeutic profit in Myoclonus
Dystonia on the severity of the myoclonus.